Affiliation:
1. Irkutsk State Medical University
2. Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education
Abstract
Significant interest in the problem of genetic oncological diseases is due to an increase in the frequency of their detection, existing difficulties of early recognition, disagreements in the clinical and morphological criteria for diagnosis and evaluation of prognostic factors, the absence of generally accepted standards of treatment and objective assessment of their results.The introduction of new diagnostic technologies into clinical practice (molecular genetic studies, the ability to determine a wide range of hormones and peptides, immunohistochemical determination of general and specific markers, modern methods of topical diagnostics, etc.) allowed us to identify a specific genetic substrate of various types of endocrine organ tumors, previously unknown nosological forms, improve the ability to predict the disease on the preclinical level, to assess their place and importance in the structure of general oncopathology.The issues of terminology, classification, criteria for the degree of malignancy and prognostic factors of hereditary endocrine diseases are particularly relevant. The article presents and analyzes the modern classification and terminological definitions of this group of diseases. The problem of hereditary endocrine tumor diseases and syndromes associated with neuroendocrine tumors (NETs) and multiple endocrine neoplasia syndromes (MEN-syndromes) has been described. In conclusion, the situation with the study of this problem in the Russian Federation is analyzed.
Reference11 articles.
1. Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs. International Agency for Research on Cancer. Lyon: IARC press; 2017.
2. Solcia E, Kloppel G, Sobin L. Histological typing of endocrine tumours. New York: Springer; 2000.
3. Bosman F, Conneiro F, Hruban R, Theise N. WHO Classification of tumours of the digestive system. Lyon: IARC press; 2010.
4. Kubyshkin VA, Kochatkov AV, Konstantinova MM, Kriger AG. The terminology, classifications and staging of neuroendocrine tumors of the pancreas. Khirurgiia. 2012; (6): 4-8. (In Russ.)
5. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010; 34(3): 300-313. doi: 10.1097/PAS.0b013e3181ce1447